BAALCis an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)

✍ Scribed by Carlos Santamaría; María C. Chillón; Ramón García-Sanz; Cristina Pérez; María D. Caballero; María V. Mateos; Fernando Ramos; Alfonso García de Coca; José M. Alonso; Pilar Giraldo; Teresa Bernal; José A. Queizán; Juan N. Rodríguez; Noemí Puig; Ana Balanzategui; María E. Sarasquete; Miguel Alcoceba; Joaquín Díaz-Mediavilla; Jesús San Miguel; Marcos González

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 185 KB
• Volume: 89
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-009-0864-x